• Explore /
  • Poster
  • / Tumor treating fields (TTFields) concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer: The phase 3 PANOVA-3 study.

Tumor treating fields (TTFields) concomitant with gemcitabine and nab-paclitaxel (GnP) for front-line treatment of locally advanced pancreatic cancer: The phase 3 PANOVA-3 study.

Abstract Poster

Authors

null

Vincent J. Picozzi

Virginia Mason Medical Center, Seattle, WA;

Vincent J. Picozzi , Teresa Macarulla , Philip A. Philip , Carlos Roberto Becerra , Tomislav Dragovich

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT01971281

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS770)

DOI

10.1200/JCO.2023.41.4_suppl.TPS770

Abstract #

TPS770

Poster Bd #

Q6

Abstract Disclosures

Similar Posters

First Author: Hani M. Babiker

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi

First Author: Vincent J. Picozzi